Elevation Oncology (NASDAQ:ELEV) Upgraded by Zacks Investment Research to Buy

Elevation Oncology stock has undergone multiple analysts rating changes in the recent past.  Elevation Oncology Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Hold.

Shares of Elevation Oncology traded down -$0.06 on Tuesday, reaching $7.73. 0 shares of the stock traded hands, compared to its average volume of 67419. Shares of Elevation Oncology were trading at $7.73 on Tuesday. The firm’s 50 day moving average is $9.79 and its 200 day moving average is N/A.Elevation Oncology has a 12 month low of $7.62 and a 12 month high of $16.22. While on yearly highs and lows, Elevation Oncology’s today has traded high as $7.85 and has touched $7.62 on the downward trend. See More Analyst Rating at: RATING

Elevation Oncology Earnings and What to expect: 

Elevation Oncology last issued its earnings data on August 12th, 2021. The reported ($4.84) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by $4.46. Elevation Oncology has generated $0.00 earnings per share over the last year. Earnings for Elevation Oncology are expected to grow in the coming year, from ($2.02) to ($1.64) per share. Elevation Oncology has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

Earnings for Elevation Oncology are expected to grow in the coming year, from ($2.02) to ($1.64) per share.

Elevation Oncology (NASDAQ:ELEV) Moving Average Technical Analysis

5 day Moving Average is $7.78 And 5 day price change is $0.22 (2.93%)  with average volume for 5 day average is 8,740. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $8.13 and 20 day price change is -$1.77 (-18.63%) and average 20 day moving volume is 77,535. 50 day moving average is $9.79  and 50 day price change is -$0.47 ( -5.73%)  and with average volume for 50 days is : 49,820. 200 day moving average is N/A  and 200 day price change is N/A (N/A)  and with average volume for 200 days is : N/A.

Other owners latest trading in Elevation Oncology :

  • On 8/17/2021 shares held by Weiss Multi Strategy Advisers LLC were 15,037 which equates to market value of $0.20M and appx 0.00% owners of Elevation Oncology
  • On 8/17/2021 shares held by Woodline Partners LP were 112,431 which equates to market value of $1.53M and appx 0.00% owners of Elevation Oncology
  • On 8/17/2021 shares held by Samsara BioCapital LLC were 932,239 which equates to market value of $12.65M and appx 1.60% owners of Elevation Oncology
  • In total Institutional ownership equates to Institutional Ownership Percentage: 69.73% for Elevation Oncology

See More Analyst Rating at: RATING